Finance

Lists
Why is 603259 down 6,60%?
Dive Deeper
603259:SHA
WuXi AppTec Co Ltd
144,30 CN¥
-6,60%
(-10,20) 1D
16 հոկ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603259...
Open
156,94 CN¥
High
159,92 CN¥
Low
139,05 CN¥
Mkt. cap
447,48 մլրդ
Avg. vol.
34,02 մլն
Volume
83,61 մլն
Dividend
1,45%
Quarterly dividend
0,52 CN¥
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
19,63
52-wk high
173,60 CN¥
52-wk low
87,09 CN¥
EPS
7,35 CN¥
Shares outstanding
1,05 մլրդ
No. of employees
36 հզր
Open
156,94 CN¥
High
159,92 CN¥
Low
139,05 CN¥
Mkt. cap
447,48 մլրդ
Avg. vol.
34,02 մլն
Volume
83,61 մլն
Dividend
1,45%
Quarterly dividend
0,52 CN¥
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
19,63
52-wk high
173,60 CN¥
52-wk low
87,09 CN¥
EPS
7,35 CN¥
Shares outstanding
1,05 մլրդ
No. of employees
36 հզր
News stories
From web sources and news partners
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees35,6 հզր
Founded01 դեկ, 2000 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,04 մլրդ
10,97 մլրդ
12,44 մլրդ
16,46 մլրդ
Cost of goods sold
6,07 մլրդ
4,91 մլրդ
6,17 մլրդ
-
Cost of revenue
6,07 մլրդ
4,91 մլրդ
6,17 մլրդ
-
Research and development expenses
311,73 մլն
236,94 մլն
266,96 մլն
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
854,49 մլն
853,67 մլն
891,80 մլն
-
Operating expense
1,38 մլրդ
1,26 մլրդ
1,22 մլրդ
-
Total operating expenses
7,45 մլրդ
6,17 մլրդ
7,39 մլրդ
-
Operating income
4,59 մլրդ
4,80 մլրդ
5,04 մլրդ
-
Other non operating income
-470,36 մլն
281,37 մլն
-266,37 մլն
-
EBT including unusual items
5,13 մլրդ
6,75 մլրդ
5,61 մլրդ
-
EBT excluding unusual items
5,11 մլրդ
6,95 մլրդ
5,19 մլրդ
-
Income tax expense
1,55 մլրդ
1,09 մլրդ
936,77 մլն
-
Effective tax rate
30,19%
16,12%
16,71%
-
Other operating expenses
57,96 մլն
25,84 մլն
726,05 հզր
-
Net income
3,51 մլրդ
7,08 մլրդ
4,65 մլրդ
-
Net profit margin
29,18%
64,49%
37,40%
-
Earnings per share
1,24
1,42
1,57
2,20
Interest and investment income
1,21 մլրդ
1,87 մլրդ
439,82 մլն
-
Interest expense
-226,71 մլն
-
-30,95 մլն
-
Net interest expenses
981,72 մլն
1,87 մլրդ
408,87 մլն
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5,21 մլրդ
5,61 մլրդ
5,85 մլրդ
-
Gain or loss from assets sale
-158,03 մլն
218,40 մլն
-
-
AI content may include mistakes. Learn more
Google Apps